HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 21, 22578-22584, May 21, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: 279/21/22578    most recent M401522200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Varga, K. Articles by Bebök, Z. Search for Related Content PubMed PubMed Citation Articles by Varga, K. Articles by Bebök, Z. Social Bookmarking                      What's this?

Efficient Intracellular Processing of the Endogenous Cystic Fibrosis Transmembrane Conductance Regulator in Epithelial Cell Lines^*

Károly Varga, Asta Jurkuvenaite, John Wakefield¶, Jeong S. Hong, Jennifer S. Guimbellot||, Charles J. Venglarik, Ashutosh Niraj, Marina Mazur, Eric J. Sorscher**, James F. Collawn, and Zsuzsa Bebök

From the Departments of Cell Biology, ^**Medicine, ^||Genetics and Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama 35294 and the ^¶Tranzyme Corporation, Birmingham, Alabama 35209

The cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-dependent protein kinase A-activated chloride channel that resides on the apical surface of epithelial cells. One unusual feature of this protein is that during biogenesis, 75% of wild type CFTR is degraded by the endoplasmic reticulum (ER)-associated degradative (ERAD) pathway. Examining the biogenesis and structural instability of the molecule has been technically challenging due to the limited amount of CFTR expressed in epithelia. Consequently, investigators have employed heterologous overexpression systems. Based on recent results that epithelial specific factors regulate both CFTR biogenesis and function, we hypothesized that CFTR biogenesis in endogenous CFTR expressing epithelial cells may be more efficient. To test this, we compared CFTR biogenesis in two epithelial cell lines endogenously expressing CFTR (Calu-3 and T84) with two heterologous expression systems (COS-7 and HeLa). Consistent with previous reports, 20 and 35% of the newly synthesized CFTR were converted to maturely glycosylated CFTR in COS-7 and HeLa cells, respectively. In contrast, CFTR maturation was virtually 100% efficient in Calu-3 and T84 cells. Furthermore, inhibition of the proteasome had no effect on CFTR biogenesis in Calu-3 cells, whereas it stabilized the immature form of CFTR in HeLa cells. Quantitative reverse transcriptase-PCR indicated that CFTR message levels are 4-fold lower in Calu-3 than HeLa cells, yet steady-state protein levels are comparable. Our results question the structural instability model of wild type CFTR and indicate that epithelial cells endogenously expressing CFTR efficiently process this protein to post-Golgi compartments.

Received for publication, February 11, 2004 , and in revised form, March 22, 2004.

^* This work was supported in part by a fellowship from the Research Development Program of the Cystic Fibrosis Foundation (CFF) (to K. V.), an American Lung Association grant (to Z. B.), National Institutes of Health Grant DK60065 (to J. F. C.), and a grant from the Research Development Program of the CFF and the National Institutes of Health (to E. J. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

This study represents a collaborative effort between the Bebõk and Collawn laboratories, and both investigators contributed equally to the supervision of the experiments.

To whom correspondence should be addressed: Dept. of Cell Biology and Gregory Fleming James CF Research Center, University of Alabama at Birmingham, MCLM 760, 1918 University Blvd., Birmingham, AL 35294-0005. Tel.: 205-975-5449; Fax: 205-934-7593; E-mail: bebok{at}uab.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				O. Prokopenko and O. Mirochnitchenko Ischemia-reperfusion-inducible protein modulates cell sensitivity to anticancer drugs by regulating activity of efflux transporter Am J Physiol Cell Physiol, May 1, 2009; 296(5): C1086 - C1097. [Abstract] [Full Text] [PDF]

				M. R. Silvis, C. A. Bertrand, N. Ameen, F. Golin-Bisello, M. B. Butterworth, R. A. Frizzell, and N. A. Bradbury Rab11b Regulates the Apical Recycling of the Cystic Fibrosis Transmembrane Conductance Regulator in Polarized Intestinal Epithelial Cells Mol. Biol. Cell, April 15, 2009; 20(8): 2337 - 2350. [Abstract] [Full Text] [PDF]

				S. Susuki, T. Sato, M. Miyata, M. Momohara, M. A. Suico, T. Shuto, Y. Ando, and H. Kai The Endoplasmic Reticulum-associated Degradation of Transthyretin Variants Is Negatively Regulated by BiP in Mammalian Cells J. Biol. Chem., March 27, 2009; 284(13): 8312 - 8321. [Abstract] [Full Text] [PDF]

				F. Chappe, M. E. Loewen, J. W. Hanrahan, and V. Chappe Vasoactive Intestinal Peptide Increases Cystic Fibrosis Transmembrane Conductance Regulator Levels in the Apical Membrane of Calu-3 Cells through a Protein Kinase C-Dependent Mechanism J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 226 - 238. [Abstract] [Full Text] [PDF]

				R. Bartoszewski, A. Rab, A. Jurkuvenaite, M. Mazur, J. Wakefield, J. F. Collawn, and Z. Bebok Activation of the Unfolded Protein Response by {Delta}F508 CFTR Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 448 - 457. [Abstract] [Full Text] [PDF]

				F. Sun, Z. Mi, S. B. Condliffe, C. A. Bertrand, X. Gong, X. Lu, R. Zhang, J. D. Latoche, J. M. Pilewski, P. D. Robbins, et al. Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia FASEB J, September 1, 2008; 22(9): 3255 - 3263. [Abstract] [Full Text] [PDF]

				R. Bartoszewski, A. Rab, G. Twitty, L. Stevenson, J. Fortenberry, A. Piotrowski, J. P. Dumanski, and Z. Bebok The Mechanism of Cystic Fibrosis Transmembrane Conductance Regulator Transcriptional Repression during the Unfolded Protein Response J. Biol. Chem., May 2, 2008; 283(18): 12154 - 12165. [Abstract] [Full Text] [PDF]

				J. Rennolds, C. Tower, L. Musgrove, L. Fan, K. Maloney, J. P. Clancy, K. L. Kirk, E. Sztul, and E. Cormet-Boyaka Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Is Mediated by the COPI Coat in Epithelial Cells J. Biol. Chem., January 11, 2008; 283(2): 833 - 839. [Abstract] [Full Text] [PDF]

				L. A. Borthwick, J. Mcgaw, G. Conner, C. J. Taylor, V. Gerke, A. Mehta, L. Robson, and R. Muimo The Formation of the cAMP/Protein Kinase A-dependent Annexin 2 S100A10 Complex with Cystic Fibrosis Conductance Regulator Protein (CFTR) Regulates CFTR Channel Function Mol. Biol. Cell, September 1, 2007; 18(9): 3388 - 3397. [Abstract] [Full Text] [PDF]

				M. W. Wendeler, O. Nufer, and H.-P. Hauri Improved maturation of CFTR by an ER export signal FASEB J, August 1, 2007; 21(10): 2352 - 2358. [Abstract] [Full Text] [PDF]

				R. F. Goldstein, A. Niraj, T. P. Sanderson, L. S. Wilson, A. Rab, H. Kim, Z. Bebok, and J. F. Collawn VCP/p97 AAA-ATPase Does Not Interact with the Endogenous Wild-Type Cystic Fibrosis Transmembrane Conductance Regulator Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 706 - 714. [Abstract] [Full Text] [PDF]

				S. Heubes and O. Stemmann The AAA-ATPase p97-Ufd1-Npl4 is required for ERAD but not for spindle disassembly in Xenopus egg extracts J. Cell Sci., April 15, 2007; 120(8): 1325 - 1329. [Abstract] [Full Text] [PDF]

				A. Rab, R. Bartoszewski, A. Jurkuvenaite, J. Wakefield, J. F. Collawn, and Z. Bebok Endoplasmic reticulum stress and the unfolded protein response regulate genomic cystic fibrosis transmembrane conductance regulator expression Am J Physiol Cell Physiol, February 1, 2007; 292(2): C756 - C766. [Abstract] [Full Text] [PDF]

				N. A. Bradbury Freedom of expression. Focus on "Endoplasmic reticulum stress and the unfolded protein response regulate cystic fibrosis transmembrane conductance regulator expression" Am J Physiol Cell Physiol, February 1, 2007; 292(2): C687 - C688. [Full Text] [PDF]

				F. Sun, R. Zhang, X. Gong, X. Geng, P. F. Drain, and R. A. Frizzell Derlin-1 Promotes the Efficient Degradation of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and CFTR Folding Mutants J. Biol. Chem., December 1, 2006; 281(48): 36856 - 36863. [Abstract] [Full Text] [PDF]

				T. E. Machen Innate immune response in CF airway epithelia: hyperinflammatory? Am J Physiol Cell Physiol, August 1, 2006; 291(2): C218 - C230. [Abstract] [Full Text] [PDF]

				S. B. Goldfarb, O. B. Kashlan, J. N. Watkins, L. Suaud, W. Yan, T. R. Kleyman, and R. C. Rubenstein Differential effects of Hsc70 and Hsp70 on the intracellular trafficking and functional expression of epithelial sodium channels PNAS, April 11, 2006; 103(15): 5817 - 5822. [Abstract] [Full Text] [PDF]

				A. Jurkuvenaite, K. Varga, K. Nowotarski, K. L. Kirk, E. J. Sorscher, Y. Li, J. P. Clancy, Z. Bebok, and J. F. Collawn Mutations in the Amino Terminus of the Cystic Fibrosis Transmembrane Conductance Regulator Enhance Endocytosis J. Biol. Chem., February 10, 2006; 281(6): 3329 - 3334. [Abstract] [Full Text] [PDF]

				J. Oberdorf, D. Pitonzo, and W. R. Skach An Energy-dependent Maturation Step Is Required for Release of the Cystic Fibrosis Transmembrane Conductance Regulator from Early Endoplasmic Reticulum Biosynthetic Machinery J. Biol. Chem., November 18, 2005; 280(46): 38193 - 38202. [Abstract] [Full Text] [PDF]

				F. Golin-Bisello, N. Bradbury, and N. Ameen STa and cGMP stimulate CFTR translocation to the surface of villus enterocytes in rat jejunum and is regulated by protein kinase G Am J Physiol Cell Physiol, September 1, 2005; 289(3): C708 - C716. [Abstract] [Full Text] [PDF]

				I. Ron and M. Horowitz ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity Hum. Mol. Genet., August 15, 2005; 14(16): 2387 - 2398. [Abstract] [Full Text] [PDF]

				C. M. Farinha and M. D. Amaral Most F508del-CFTR Is Targeted to Degradation at an Early Folding Checkpoint and Independently of Calnexin Mol. Cell. Biol., June 15, 2005; 25(12): 5242 - 5252. [Abstract] [Full Text] [PDF]

				J. Shepshelovich, L. Goldstein-Magal, A. Globerson, P. M. Yen, P. Rotman-Pikielny, and K. Hirschberg Protein synthesis inhibitors and the chemical chaperone TMAO reverse endoplasmic reticulum perturbation induced by overexpression of the iodide transporter pendrin J. Cell Sci., April 15, 2005; 118(8): 1577 - 1586. [Abstract] [Full Text] [PDF]

				M. Sugita, H. Kongo, and Y. Shiba Molecular Dissection of the Butyrate Action Revealed the Involvement of Mitogen-Activated Protein Kinase in Cystic Fibrosis Transmembrane Conductance Regulator Biogenesis Mol. Pharmacol., November 1, 2004; 66(5): 1248 - 1259. [Abstract] [Full Text] [PDF]